T1	total-participants 438 440	80
T2	eligibility 441 560	patients with nonpalpable breast cancer without axillary adenopathies who were scheduled for primary surgical treatment
T4	intervention-participants 669 671	35
T6	control-participants 734 736	45
T7	outcome 912 944	rates of sentinel node detection
T8	iv-bin-percent 950 955	97.1%
T9	iv-bin-abs 957 959	34
T10	intervention-participants 960 962	35
T11	cv-bin-percent 995 1000	84.4%
T12	cv-bin-abs 1002 1004	38
T13	control-participants 1005 1007	45
T14	outcome 1036 1065	Radiotracer migration failure
T15	iv-bin-abs 1087 1090	one
T16	cv-bin-abs 1114 1115	7
T17	outcome 1140 1196	sentinel node was detected in an extra-axillary location
T18	iv-bin-abs 1216 1218	11
T19	intervention-participants 1219 1221	59
T20	cv-bin-abs 1245 1247	16
T21	control-participants 1248 1250	64
T22	intervention 20 32	intratumoral
T5	control 37 73	peritumoral injection of radiotracer
